Exploiting Signaling Pathways and Immune Targets Beyond the Standard of Care for Ewing Sarcoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exploiting Signaling Pathways and Immune Targets Beyond the Standard of Care for Ewing Sarcoma
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-06-19
DOI
10.3389/fonc.2019.00537
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial
- (2018) Mark M Souweidane et al. LANCET ONCOLOGY
- Phase 1 trial of ontuxizumab (MORAb-004) in children with relapsed or refractory solid tumors: A report from the Children's Oncology Group Phase 1 Pilot Consortium (ADVL1213)
- (2018) Robin E. Norris et al. PEDIATRIC BLOOD & CANCER
- Immunohistochemical analysis and prognostic significance of PD-L1, PD-1, and CD8+ tumor-infiltrating lymphocytes in Ewing’s sarcoma family of tumors (ESFT)
- (2018) Isidro Machado et al. VIRCHOWS ARCHIV
- Recombinant methioninase combined with doxorubicin (DOX) regresses a DOX-resistant synovial sarcoma in a patient-derived orthotopic xenograft (PDOX) mouse model
- (2018) Kentaro Igarashi et al. Oncotarget
- Pediatric Cancer Immunotherapy: Opportunities and Challenges
- (2018) Mary Frances Wedekind et al. PEDIATRIC DRUGS
- CD99 at the crossroads of physiology and pathology
- (2018) Michela Pasello et al. Journal of Cell Communication and Signaling
- High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008
- (2018) Jeremy Whelan et al. JOURNAL OF CLINICAL ONCOLOGY
- Identifying the druggable interactome of EWS-FLI1 reveals MCL-1 dependent differential sensitivities of Ewing sarcoma cells to apoptosis inducers
- (2018) Kalliopi Tsafou et al. Oncotarget
- The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth
- (2018) Janet K. Parrish et al. Oncotarget
- Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial
- (2018) Ruth Ladenstein et al. LANCET ONCOLOGY
- Irinotecan–temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial
- (2017) Rajen Mody et al. LANCET ONCOLOGY
- DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma
- (2017) Nathan C Sheffield et al. NATURE MEDICINE
- Radiotherapy and immunotherapy: a beneficial liaison?
- (2017) Ralph R. Weichselbaum et al. Nature Reviews Clinical Oncology
- Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
- (2017) Scott J. Antonia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recombinant methioninase effectively targets a Ewing’s sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model
- (2017) Takashi Murakami et al. Oncotarget
- Ewing sarcoma partial regression without GvHD by chondromodulin-I/HLA-A*02:01-specific allorestricted T cell receptor transgenic T cells
- (2017) Uwe Thiel et al. OncoImmunology
- Activity of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF1R), in patients (pts) with recurrent or refractory Ewing's sarcoma family of tumors (ESFT): Results of a phase II SARC study.
- (2017) A. S. Pappo et al. JOURNAL OF CLINICAL ONCOLOGY
- Intratumoral Heterogeneity of the Epigenome
- (2016) Tali Mazor et al. CANCER CELL
- Identification of Mithramycin Analogues with Improved Targeting of the EWS-FLI1 Transcription Factor
- (2016) Christy L. Osgood et al. CLINICAL CANCER RESEARCH
- Adjuvant Immunotherapy to Improve Outcome in High-Risk Pediatric Sarcomas
- (2016) M. S. Merchant et al. CLINICAL CANCER RESEARCH
- Phase 1 study of dalotuzumab monotherapy and ridaforolimus–dalotuzumab combination therapy in paediatric patients with advanced solid tumours
- (2016) Didier Frappaz et al. EUROPEAN JOURNAL OF CANCER
- Englerin A Inhibits EWS-FLI1 DNA Binding in Ewing Sarcoma Cells
- (2016) Vittorio Caropreso et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Management and follow-up of Ewing sarcoma patients with isolated lung metastases
- (2016) Anna Raciborska et al. JOURNAL OF PEDIATRIC SURGERY
- A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma
- (2016) Peter M. Anderson et al. PEDIATRIC BLOOD & CANCER
- Oncotargets GD2 and GD3 are highly expressed in sarcomas of children, adolescents, and young adults
- (2016) Konstantin Dobrenkov et al. PEDIATRIC BLOOD & CANCER
- A systematic review of optimal treatment strategies for localized Ewing's sarcoma of bone after neo-adjuvant chemotherapy
- (2016) Joel Werier et al. SURGICAL ONCOLOGY-OXFORD
- PARP Inhibitors Sensitize Ewing Sarcoma Cells to Temozolomide-Induced Apoptosis via the Mitochondrial Pathway
- (2015) F. Engert et al. MOLECULAR CANCER THERAPEUTICS
- Receptor tyrosine kinase gene expression profiles of Ewing sarcomas reveal ROR1 as a potential therapeutic target in metastatic disease
- (2015) Jenny Potratz et al. Molecular Oncology
- Pilot Trial of FANG Immunotherapy in Ewing's Sarcoma
- (2015) Maurizio Ghisoli et al. MOLECULAR THERAPY
- Ifosfamide dose-intensification for patients with metastatic Ewing sarcoma
- (2015) Heather Magnan et al. PEDIATRIC BLOOD & CANCER
- YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model
- (2015) Tsion Zewdu Minas et al. Oncotarget
- The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies
- (2015) Leisha A. Emens et al. Cancer Immunology Research
- Targeted immunotherapy for pediatric solid tumors
- (2015) Lisa M. Kopp et al. OncoImmunology
- Role of Local Radiation Therapy in Cancer Immunotherapy
- (2015) Sandra Demaria et al. JAMA Oncology
- Abstract 999: The genomic landscape of pediatric Ewing sarcoma
- (2015) Brian Crompton et al. CANCER RESEARCH
- The role of AXL and the in vitro activity of the receptor tyrosine kinase inhibitor BGB324 in Ewing sarcoma
- (2015) Emmy D.G. Fleuren et al. Oncotarget
- Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapy
- (2014) Edwin Choy et al. BMC CANCER
- Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: A report from the Children's Oncology Group
- (2014) Steven G. DuBois et al. CANCER
- Reversible LSD1 Inhibition Interferes with Global EWS/ETS Transcriptional Activity and Impedes Ewing Sarcoma Tumor Growth
- (2014) S. Sankar et al. CLINICAL CANCER RESEARCH
- Phase I Trial of a Bivalent Gangliosides Vaccine in Combination with β-Glucan for High-Risk Neuroblastoma in Second or Later Remission
- (2014) Brian H. Kushner et al. CLINICAL CANCER RESEARCH
- CD99 Triggering in Ewing Sarcoma Delivers a Lethal Signal through p53 Pathway Reactivation and Cooperates with Doxorubicin
- (2014) C. Guerzoni et al. CLINICAL CANCER RESEARCH
- Development of recombinant methioninase to target the general cancer-specific metabolic defect of methionine dependence: a 40-year odyssey
- (2014) Robert M Hoffman EXPERT OPINION ON BIOLOGICAL THERAPY
- A phase 1, open-label, dose-escalation study of BIIB022 (anti-IGF-1R monoclonal antibody) in subjects with relapsed or refractory solid tumors
- (2014) Margaret von Mehren et al. INVESTIGATIONAL NEW DRUGS
- Safety profile of long-term intraventricular access devices in pediatric patients receiving radioimmunotherapy for central nervous system malignancies
- (2014) Kim Kramer et al. PEDIATRIC BLOOD & CANCER
- Phase II study of cixutumumab in combination with temsirolimus in pediatric patients and young adults with recurrent or refractory sarcoma: A report from the children's oncology group
- (2014) Lars M. Wagner et al. PEDIATRIC BLOOD & CANCER
- GD2-Targeted Immunotherapy and Radioimmunotherapy
- (2014) Konstantin Dobrenkov et al. SEMINARS IN ONCOLOGY
- Getting Syk: spleen tyrosine kinase as a therapeutic target
- (2014) Robert L. Geahlen TRENDS IN PHARMACOLOGICAL SCIENCES
- Stereotactic Radiation Therapy Augments Antigen-Specific PD-1-Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen
- (2014) A. B. Sharabi et al. Cancer Immunology Research
- Characterization of Ewing sarcoma associated cancer/testis antigens
- (2013) Dorothea E. Mahlendorf et al. CANCER BIOLOGY & THERAPY
- Targeting ROR1 Inhibits Epithelial-Mesenchymal Transition and Metastasis
- (2013) B. Cui et al. CANCER RESEARCH
- Targeted Imaging of Ewing Sarcoma in Preclinical Models Using a 64 Cu-Labeled Anti-CD99 Antibody
- (2013) Allison F. O'Neill et al. CLINICAL CANCER RESEARCH
- Engineering anti-GD2 monoclonal antibodies for cancer immunotherapy
- (2013) Mahiuddin Ahmed et al. FEBS LETTERS
- B7-H3-mediated tumor immunology: Friend or foe?
- (2013) Ling Wang et al. INTERNATIONAL JOURNAL OF CANCER
- The dual inhibitory effect of thiostrepton on FoxM1 and EWS/FLI1 provides a novel therapeutic option for Ewing’s sarcoma
- (2013) ANIRUDDHA SENGUPTA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Phase I Pharmacokinetic and Pharmacodynamic Study of Pazopanib in Children With Soft Tissue Sarcoma and Other Refractory Solid Tumors: A Children's Oncology Group Phase I Consortium Report
- (2013) Julia L. Glade Bender et al. JOURNAL OF CLINICAL ONCOLOGY
- Combining PARP-1 Inhibition and Radiation in Ewing Sarcoma Results in Lethal DNA Damage
- (2013) Hae-June Lee et al. MOLECULAR CANCER THERAPEUTICS
- Suppression of FOXO1 is responsible for a growth regulatory repressive transcriptional sub-signature of EWS-FLI1 in Ewing sarcoma
- (2013) S Niedan et al. ONCOGENE
- FOXM1 Is an Oncogenic Mediator in Ewing Sarcoma
- (2013) Laura Christensen et al. PLoS One
- Anti-VEGFR2 and anti-IGF-1R-Adnectins inhibit Ewing’s sarcoma A673-xenograft growth and normalize tumor vascular architecture
- (2012) Maximilian Ackermann et al. ANGIOGENESIS
- High STEAP1 expression is associated with improved outcome of Ewing's sarcoma patients
- (2012) T. G. P. Grunewald et al. ANNALS OF ONCOLOGY
- Phase I study of humanized monoclonal antibody AVE1642 directed against the type 1 insulin-like growth factor receptor (IGF-1R), administered in combination with anticancer therapies to patients with advanced solid tumors
- (2012) V. M. Macaulay et al. ANNALS OF ONCOLOGY
- The ganglioside antigen GD2 is surface-expressed in Ewing sarcoma and allows for MHC-independent immune targeting
- (2012) S Kailayangiri et al. BRITISH JOURNAL OF CANCER
- Crosstalk between ROR1 and the Pre-B Cell Receptor Promotes Survival of t(1;19) Acute Lymphoblastic Leukemia
- (2012) Vincent T. Bicocca et al. CANCER CELL
- PARP-1 Inhibition as a Targeted Strategy to Treat Ewing's Sarcoma
- (2012) J. C. Brenner et al. CANCER RESEARCH
- Insulin Growth Factor-Receptor (IGF-1R) Antibody Cixutumumab Combined with the mTOR Inhibitor Temsirolimus in Patients with Refractory Ewing's Sarcoma Family Tumors
- (2012) A. Naing et al. CLINICAL CANCER RESEARCH
- EWS-FLI-1-Targeted Cytotoxic T-cell Killing of Multiple Tumor Types Belonging to the Ewing Sarcoma Family of Tumors
- (2012) C. H. Evans et al. CLINICAL CANCER RESEARCH
- Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: A predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas
- (2012) Irène Asmane et al. EUROPEAN JOURNAL OF CANCER
- Murine Anti-GD2 Monoclonal Antibody 3F8 Combined With Granulocyte-Macrophage Colony-Stimulating Factor and 13-Cis-Retinoic Acid in High-Risk Patients With Stage 4 Neuroblastoma in First Remission
- (2012) Nai-Kong V. Cheung et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Ganitumab, a Fully Human Anti–Type-1 Insulin-Like Growth Factor Receptor Antibody, in Patients With Metastatic Ewing Family Tumors or Desmoplastic Small Round Cell Tumors
- (2012) William D. Tap et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Trial and Pharmacokinetic Study of Lexatumumab in Pediatric Patients With Solid Tumors
- (2012) Melinda S. Merchant et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Controlled Trial of Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma: A Report From the Children's Oncology Group
- (2012) Richard B. Womer et al. JOURNAL OF CLINICAL ONCOLOGY
- ROR1 Is Expressed in Human Breast Cancer and Associated with Enhanced Tumor-Cell Growth
- (2012) Suping Zhang et al. PLoS One
- Novel peptide binds EWS-FLI1 and reduces the oncogenic potential in Ewing tumors
- (2011) Hayriye V. Erkizan et al. CELL CYCLE
- Detection of N-Glycolyl GM3 Ganglioside in Neuroectodermal Tumors by Immunohistochemistry: An Attractive Vaccine Target for Aggressive Pediatric Cancer
- (2011) Alejandra M. Scursoni et al. Clinical & Developmental Immunology
- Immunogenicity and safety of a NeuGcGM3 based cancer vaccine: Results from a controlled study in metastatic breast cancer patients.
- (2011) Vladimir Mulens et al. Human vaccines & immunotherapeutics
- Targeting of Insulin-Like Growth Factor Type 1 Receptor in Ewing Sarcoma: Unfulfilled Promise or a Promising Beginning?
- (2011) Alan L. Ho et al. JOURNAL OF CLINICAL ONCOLOGY
- Preliminary Efficacy of the Anti-Insulin–Like Growth Factor Type 1 Receptor Antibody Figitumumab in Patients With Refractory Ewing Sarcoma
- (2011) Heribert Juergens et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I/II Trial and Pharmacokinetic Study of Cixutumumab in Pediatric Patients With Refractory Solid Tumors and Ewing Sarcoma: A Report From the Children's Oncology Group
- (2011) Suman Malempati et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of Ganitumab (AMG 479), Alone and in Combination with Rapamycin, in Ewing's and Osteogenic Sarcoma Models
- (2011) P. J. Beltran et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- EGFR Inhibition Fails to Suppress Vascular Proliferation and Tumor Growth in a Ewing's Sarcoma Model
- (2011) Artur Chernoguz et al. JOURNAL OF SURGICAL RESEARCH
- STEAP1 Is Associated with the Invasive and Oxidative Stress Phenotype of Ewing Tumors
- (2011) T. G. P. Grunewald et al. MOLECULAR CANCER RESEARCH
- FOXO1 is a direct target of EWS-Fli1 oncogenic fusion protein in Ewing’s sarcoma cells
- (2010) Liu Yang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Endosialin/TEM-1/CD248 regulates pericyte proliferation through PDGF receptor signaling
- (2010) Brian Tomkowicz et al. CANCER BIOLOGY & THERAPY
- A Phase I Study of Weekly R1507, A Human Monoclonal Antibody Insulin-like Growth Factor-I Receptor Antagonist, in Patients with Advanced Solid Tumors
- (2010) R. Kurzrock et al. CLINICAL CANCER RESEARCH
- Cytotoxicity of Activated Natural Killer Cells against Pediatric Solid Tumors
- (2010) D. Cho et al. CLINICAL CANCER RESEARCH
- EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells
- (2010) N. Riggi et al. GENES & DEVELOPMENT
- CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis
- (2010) Anna Rocchi et al. JOURNAL OF CLINICAL INVESTIGATION
- Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway
- (2010) Elspeth M. Beauchamp et al. JOURNAL OF CLINICAL INVESTIGATION
- Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8+ T-lymphocyte infiltration and affect tumour progression
- (2010) Dagmar Berghuis et al. JOURNAL OF PATHOLOGY
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
- (2010) Alice L. Yu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase I and pharmacokinetic study of lexatumumab (HGS-ETR2) given every 2 weeks in patients with advanced solid tumors
- (2009) H. A. Wakelee et al. ANNALS OF ONCOLOGY
- The Insulin-like Growth Factor-1 Receptor-Targeting Antibody, CP-751,871, Suppresses Tumor-Derived VEGF and Synergizes with Rapamycin in Models of Childhood Sarcoma
- (2009) R. T. Kurmasheva et al. CANCER RESEARCH
- GLI1 Is a Direct Transcriptional Target of EWS-FLI1 Oncoprotein
- (2009) Elspeth Beauchamp et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dose-Intensified Compared With Standard Chemotherapy for Nonmetastatic Ewing Sarcoma Family of Tumors: A Children's Oncology Group Study
- (2009) Linda Granowetter et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I, Pharmacokinetic, and Pharmacodynamic Study of AMG 479, a Fully Human Monoclonal Antibody to Insulin-Like Growth Factor Receptor 1
- (2009) Anthony W. Tolcher et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Multicenter Trial of Imatinib in 10 Histologic Subtypes of Sarcoma Using a Bayesian Hierarchical Statistical Model
- (2009) Rashmi Chugh et al. JOURNAL OF CLINICAL ONCOLOGY
- Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma
- (2009) Kim Kramer et al. JOURNAL OF NEURO-ONCOLOGY
- Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study
- (2009) David Olmos et al. LANCET ONCOLOGY
- A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcoma
- (2009) Hayriye V Erkizan et al. NATURE MEDICINE
- EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation
- (2009) G. H. S. Richter et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Endosialin (Tem1) Is a Marker of Tumor-Associated Myofibroblasts and Tumor Vessel-Associated Mural Cells
- (2008) Sven Christian et al. AMERICAN JOURNAL OF PATHOLOGY
- Proliferation of Ewing sarcoma cell lines is suppressed by the receptor tyrosine kinase inhibitors gefitinib and vandetanib
- (2008) Mattias K Andersson et al. Cancer Cell International
- EWS-FLI-1 Expression Triggers a Ewing's Sarcoma Initiation Program in Primary Human Mesenchymal Stem Cells
- (2008) N. Riggi et al. CANCER RESEARCH
- Endosialin Protein Expression and Therapeutic Target Potential in Human Solid Tumors: Sarcoma versus Carcinoma
- (2008) C. Rouleau et al. CLINICAL CANCER RESEARCH
- Methionine depletion with recombinant methioninase:In vitroandin vivoefficacy against neuroblastoma and its synergism with chemotherapeutic drugs
- (2008) Jian Hu et al. INTERNATIONAL JOURNAL OF CANCER
- Changes in Incidence and Survival of Ewing Sarcoma Patients Over the Past 3 Decades
- (2008) Natia Esiashvili et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways
- (2008) Dirk H.J. Verhoeven et al. MOLECULAR IMMUNOLOGY
- Membrane-associated phospholipase A1 beta (LIPI) Is an Ewing tumour-associated cancer/testis antigen
- (2008) Juergen L. Foell et al. PEDIATRIC BLOOD & CANCER
- Initial testing (stage 1) of a monoclonal antibody (SCH 717454) against the IGF-1 receptor by the pediatric preclinical testing program
- (2008) E. Anders Kolb et al. PEDIATRIC BLOOD & CANCER
- IGF1 Is a Common Target Gene of Ewing's Sarcoma Fusion Proteins in Mesenchymal Progenitor Cells
- (2008) Luisa Cironi et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started